NCT00005085View on ClinicalTrials.gov

Rebeccamycin Analog in Treating Patients With Metastatic or Locally Recurrent Colorectal Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

February 29, 2000

Primary Completion Date

June 30, 2002

Conditions
Colorectal Cancer
Interventions
DRUG

becatecarin

Trial Locations (3)

10461

Albert Einstein Comprehensive Cancer Center, The Bronx

10595

New York Medical College, Valhalla

30342

Atlanta Cancer Care, Atlanta

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00005085 - Rebeccamycin Analog in Treating Patients With Metastatic or Locally Recurrent Colorectal Cancer | Biotech Hunter | Biotech Hunter